Scientific Programme
Thursday, 20 November 2025
Virtual
15:00 – 15:10 CET
Welcome and IntroductionOliver Schnell (Munich, Germany)
15:10 – 16:15 CET
New Horizons in Cardiovascular, Kidney and Metabolic CareChairs: Jennifer Green (Durham, NC, USA), John McMurray (Glasgow, UK)
15:10 – 15:25
On the Evolution of CardioVascular Outcome Trials (CVOTs)Scott Solomon (Boston, USA)
15:25 – 15:45
SURPASSing Previous Boundaries: Incretin Mimetics and Cardiorenal OutcomesStefano del Prato (Pisa, Italy)
15:45 – 16:00
The Aldosterone Pathway Revisited: Novel Approaches in Hypertension ManagementMichel Azizi (Paris, France)
16:00 – 16:15
Discussion
16:15 – 17:30 CET
From Study to Guideline to Practice: Making Clinical Evidence WorkChairs: Helena Rodbard (Rockville, MD, USA), Frank Tacke (Berlin, Germany)
16:15 – 16:30
Perspectives of the Guideline Workshop (1) Obesity: New Opportunities for Network Meta-AnalysesArnav Agarwal (Hamilton, Canada)
16:30 – 16:45
Perspectives of the Guideline Workshop (2) Implementation of Guidelines at National Level: Perspectives of the European Renal Association (ERA)Christoph Wanner (Wuerzburg, Germany)
16:45 – 17:00
Breaking Barriers in Hard to Control Hypertension: Key Insights for PractitionersKamlesh Khunti (Leicester, UK)
17:00 – 17:15
Putting Person-Centered Care into Practice: What Matters to Patients with Chronic Liver DiseaseMarko Korenjak (Brussels, Belgium)
17:15 – 17:30
Discussion
17:30 – 17:45 CET
Break
17:45 – 18:30 CET
Policy Session: Transforming Cardiometabolic Health: Advancing Science, Integrated Care and Policy
18:30 – 19:30 CET
Hellmut Mehnert AwardChairs: Rury Holman (Oxford UK), Eberhard Standl (Munich, Germany)
18:30 – 18:40
Introduction of the AwardRury Holman (Oxford UK)
18:40 – 18:45
Laudation and Presentation of AwardeeRury Holman (Oxford, UK)
18:45 – 19:25
The Discovery of Multi-Receptor Drugs: The end of obesity and type 2 diabetes?Matthias Tschöp (Munich, Germany)
19:25 – 19:30
ClosingRury Holman (Oxford UK), Eberhard Standl (Munich, Germany)
19:30 – 20:15 CET
Oral Presentations – Part 1Chairs: Dipesh Patel (London, UK), Nikolaos Papanas (Alexandroupolis, Greece)
OP 1: Prediabetes Remission and Long-Term Risk of Cardiovascular Death, Heart Failure Hospitalization, and All-Cause MortalityAndreas Birkenfeld (Tübingen, Germany)
OP 2: Clinical association of diabetes mellitus and heart failure with metabolic dysfunction-associated steatotic liver diseaseKateryna Pivtorak (Vinnytsia, Ukraine)
OP 3: Relationship between undiagnosed diabetes, cardiovascular events and mortality in acute coronary syndrome patients enrolled in the STRONG-MI registryFaisal Aziz (Graz, Austria)
OP 4: Influence of Diabetes Mellitus on Thrombosis in Branch Retinal Vein OcclusionMarianne Shahsuvaryan (Yerevan, Armenia)
20:15 CET
Closing Day 1Oliver Schnell (Munich, Germany)
Friday, 21 November 2025
Virtual
08:45 – 09:30 CET
Advancing Early Detection and Preventive Strategies in Type 1 DiabetesChair:Thomas Danne (Lisbon, Portugal)
08:45 – 09:00
C-Peptide as a Surrogate Parameter for Residual Beta Cell Function in Type 1 Diabetes and its Potential Clinical RoleColin M. Dayan (Cardiff, UK)
09:00 – 09:15
Targeting Autoimmunity in Type 1 Diabetes: Emerging Disease-Modifying StrategiesChantal Mathieu (Leuven, Belgium)
09:15 – 09:30
Discussion
09:30 – 10:30 CET
Continuous Monitoring: Current and Emerging PerspectivesChair: Julia Mader (Graz, Austria)
09:30 – 09:45
The Heartbeat of Glucose: CGM’s Role in Cardiovascular Outcomes in DiabetesTadej Battelino (Ljubljana, Slovenia)
09:45 – 10:00
Building CGM Expertise: Recommendations for Education and PracticePratik Choudhary (Leicester, UK)
10:00 – 10:15
Continuous Ketone Monitoring: A New Era in Metabolic ManagementSusanne Reger-Tan (Bad Oeynhausen, Germany)
10:15 – 10:30
Discussion
10:30 - 10:40
Break
10:40 - 10:55
Satellite Symposium
See Further, Act Smarter: How AI Is Transforming Diabetes CareJohn Pemberton (Birmingham, UK)Supported by Roche Diagnostics International Ltd.
See Further, Act Smarter: How AI Is Transforming Diabetes CareJohn Pemberton (Birmingham, UK)Supported by Roche Diagnostics International Ltd.
10:55 - 11:00
Break
11:00 – 12:00 CET
The Silent Link: Diabetes and Chronic Kidney DiseaseChairs: Rury Holman (Oxford, UK), Paola Fioretto (Padua, Italy)
11:00 – 11:15
Kidney Protection in Type 1 Diabetes: Are Non-Steroidal MRAs the Next Step?Hiddo Heerspink (Groningen, The Netherlands)
11:15 – 11:30
SGLT2 Inhibitors and Non-Steroidal MRAs: Combining Forces for Cardiorenal ProtectionJohannes Mann (Munich, Germany)
11:30 – 11:45
Future Directions in the Treatment of Chronic Kidney DiseaseParminder Judge (Oxford, UK)
11:45 - 12:00
Discussion
12:00 – 13:00 CET
Integrated Approaches in Heart Failure TherapyChairs: Naoki Sato (Kawaguchi, Japan), Henrike Arfsten (Vienna, Austria)
12:00 – 12:15
SGLT2 Inhibitors – Changing the Game in Heart Failure TreatmentNikolaus Marx (Aachen, Germany)
12:15 – 12:30
Changing Landscape in HFpEF: New Therapeutic StrategiesPardeep Jhund (Glasgow, UK)
12:30 – 12:45
Emerging Treatment Strategies in HFrEFGiuseppe Rosano (London, UK)
12:45 – 13:00
Discussion
13:00 – 13:30 CET
Break
13:30 – 15:00 CET
Multidisciplinary Strategies in Obesity and Metabolic Liver DisordersChairs: Matthias Blüher (Leipzig, Germany), Linong Ji (Beijing, China)
13:30 – 13:45
Obesity 2025 – State of the Art in Diagnosis and Therapytba
13:45 – 14:00
One Target Is Not Enough? Novel GLP-1-Based Treatment ApproachesSean Wharton (Toronto, Canada)
14:00 – 14:15
Discussion
14:15 – 14:30
The Liver in Distress: Managing Obesity-Related MASLDElisabetta Bugianesi (Turin, Italy)
14:30 – 14:45
Nutrition Under Incretin TherapyAndreas Pfeiffer (Berlin, Germany)
14:45 – 15:00
Discussion
15:00 – 15:30 CET
The Global Alliance for Cardio-Kidney-Metabolic Care – Holistic Approaches to Improve Clinical CareChairs: Stephan Jacob (Villingen-Schwenningen, Germany), Andrew Krentz (London, UK)
15:00 – 15:15
Beyond LDL Lowering: Managing the Residual Risk in ASCVDPeter Libby (Boston, MA, USA)
15:15 – 15:30
Why Do We Need to Establish Cardio-Metabolic-Renal Care and Beyond?Robert Eckel (Denver, CO, USA)
15:30 – 16:30 CET
Practical Implementation in Primary Care: A Hands-On SessionChairs: Pinar Topsever (Istanbul, Turkey), Baruch Itzhak (Haifa, Israel)
15:30 – 15:45
Why Early Diagnosis Matters, and How to Put It into Practice in Chronic Kidney DiseaseAna María Cebrián Cuenca (Murcia, Spain)
15:45 – 16:00
Supporting Patient Adherence – Practical Strategies for Clinical PracticeKatharine Barnard-Kelly (Hampshire, UK)
16:00 – 16:15
Translating Guidelines into Practice: A Heart Failure Nurse’s PerspectiveEkaterini Lambrinou (Limassol, Cyprus)
16:15 – 16:30
Discussion
16:30 – 16:45
Break
16:45 – 17:45 CET
Industry’s Perspective – Panel DiscussionOliver Schnell (Munich, Germany)
17:45 – 18:30 CET
Oral Presentations – Part 2Chair: Banshi Saboo (Ahmedabad, India)
OP 5: A Time In Range of 70% Attenuates the Senescence-Inducing and Pro-Inflammatory Effects of HyperglycemiaRosalba La Grotta (Milan, Italy)
OP 6: Monitoring ketone levels continuously during a 7-day fastNina Jendrike (Ulm, Germany)
OP 7: Routine Biopsychosocial Care Is Practical and AchievableKatharine Barnard-Kelly (Fareham, UK)
OP 8: Pharmacist-Led Consultations for Continuous Glucose Monitoring Users: Knowledge, Confidence, and Opportunities to Support Diabetes Management and OutcomesAnastasija Levkina (Vilnius, Lithuania)
18:30 – 18:45 CET
Abstract Award and ClosingOliver Schnell (Munich, Germany)